10 Horizon Pharma Analyst Ratings, Earnings, Dividends and Insider Trades | $HZNP | NASDAQ:HZNP | Analyst Ratings Network Follow @RatingsNetwork Find a Company: Login Stock Ratings Today's Ratings U.S. Analyst Ratings (NYSE and NASDAQ) All U.S. Ratings Upgrades Downgrades New Coverage Price Target Changes Rating Reiterations Canadian Analyst Ratings (TSE and TSV) U.K. Analyst Ratings (LSE) Australian Analyst Ratings (ASX) Lookup Company Ratings Free Ratings Newsletter ARN Daily Premium ($) RatingsDB ($) Stock Ratings App Earnings Today's Announcements Tomorrow's Announcements Free Earnings Newsletter CER Wire Premium ($) Lookup Company Earnings Dividends Insider Trades About Contact Horizon Pharma Company Profile (NASDAQ:HZNP) Tweet Analyst RatingsEarningsDividendsInsider TradesCompany ProfileSocial ActivityToday's Chart Consensus Ratings for Horizon Pharma (NASDAQ:HZNP) (?) The ratings breakdown includes the most recent rating from each analyst that has rated the stock within the last twelve months. The ratings score is a calculation of the average number of sell, hold, buy and strong buy ratings (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). The consensus price target is a mean average of the most recent price target set by each analyst that has set a price target for the stock in the last twelve months.Ratings Breakdown: 2 Hold Rating(s), 4 Buy Rating(s)Consensus Rating:Buy (Score: 2.67)Consensus Price Target: $13.43 (1.92% upside) Analysts' Ratings History for Horizon Pharma (NASDAQ:HZNP) Show: All Ratings For This Stock Only the Most Recent Rating From Each Brokerage DateFirmActionRatingPrice TargetDetailsShare3/5/2014Piper JaffrayBoost Price Target$21.00View 2/25/2014TheStreetUpgradeSell -> HoldView 2/19/2014R. F. LaffertyBoost Price TargetBuy$11.00 -> $13.00View 2/3/2014Piper JaffrayBoost Price Target$7.00 -> $17.00View 2/5/2014ZacksDowngradeOutperform -> Neutral$10.60View 1/30/2014JMP SecuritiesBoost Price TargetOutperform$10.00 -> $16.00View 1/29/2014R. F. LaffertyBoost Price TargetBuy$9.00 -> $11.00View 1/7/2014ZacksUpgradeNeutral -> Outperform$8.80View 11/20/2013Piper JaffrayReiterated RatingBuy$7.00View 11/20/2013Stifel NicolausBoost Price TargetBuy$7.00 -> $10.00View 11/20/2013JMP SecuritiesBoost Price TargetMarket Outperform$8.00 -> $10.00View 11/19/2013Cowen and CompanyBoost Price TargetOutperform$6.50 -> $10.00View 10/21/2013Piper JaffrayUpgradeNeutral -> Overweight$3.00 -> $7.00View 10/3/2013R. F. LaffertyInitiated CoverageBuy$6.00View 3/19/2013Piper JaffrayReiterated RatingNeutralView 1/3/2013Piper JaffrayInitiated CoverageNeutralView (Data available from 3/8/2012 forward) Earnings History for Horizon Pharma (NASDAQ:HZNP)DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetailsShare11/8/2013Q3 13($0.25)($0.03)$18.31 million$31.50 millionViewN/AView 8/9/2013Q213($0.32)($0.24)$16.09 million$17.64 millionViewN/AView 5/10/2013Q113($0.35)($0.30)$9.47 million$9.20 millionViewN/AView 11/13/2012Q312($0.68)($0.39)$4.12 million$7.20 millionViewN/AView (Data available from 1/1/2011 forward) Dividend History for Horizon Pharma (NASDAQ:HZNP)No dividend announcements for this company have been tracked by Analyst Ratings Network Insider Trading History for Horizon Pharma (NASDAQ:HZNP)Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionSEC LinkShare12/13/2013Jeffrey BirdDirectorBuy668,673$6.50$4,346,374.50View 12/9/2013Timothy WalbertCEOSell12,124$6.79$82,321.96View 12/9/2013Todd SmithEVPSell11,322$6.91$78,235.02View 11/21/2013Jeffrey BirdDirectorBuy151,089$6.24$942,795.36View 9/25/2012Jeffrey W BirdDirectorBuy575,356$3.49$2,007,992.44View (Data available from 1/1/2013 forward) About Horizon Pharma Horizon Pharma, Inc. operates as a biopharmaceutical company. It is focused on developing and commercializing medicines to target unmet therapeutic needs in arthritis, pain and inflammatory diseases. Headlines: (3/6) Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) (3/6) Horizon Pharma to Present at the 26th Annual ROTH Conference (3/5) Horizon Pharma Names Robert F. Carey Executive Vice President and Chief Business Officer (2/25) Can Horizon Pharma (HZNP) Run Higher on Strong Earnings Estimate Revisions? (2/27) Horizon Pharma to Host Conference Call and Webcast to Discuss Fourth Quarter and Full Year 2013 Financial Results on ... (2/24) Horizon Pharma to Present at the Cowen and Company 34th Annual Health Care Conference (2/24) Should You Worry About the Short Interest in Horizon Pharma (HZNP)? (3/5) Financial Results Releases and Schedules, Clinical Study Results, Partnerships, and Senior-Level Appointments ... Industry, Sector and Symbol: Sector: Healthcare Industry: Pharmaceuticals Sub-Industry: Pharmaceuticals Exchange: NASDAQ Symbol: HZNP CUSIP: 44047T10 Key Metrics: Previous Close: $13.0550 Day Moving Average: $10.5832200 Day Moving Average: $6.3756 P/E Ratio: N/AP/E Growth: N/AMarket Cap: $868.0MCurrent Quarter EPS Consensus Estimate: $-0.81 EPS Additional Links: View HZNP on Google FinanceView HZNP on Yahoo FinanceView HZNP's Company Profile on ReutersSearch for Horizon Pharma Inc on Google Horizon Pharma (NASDAQ:HZNP) Chart for Saturday, March, 8, 2014 (Chart Provided by Yahoo Finance) © Analyst Ratings Network 2010-2014. All rights reserved. Contact | Terms and Conditions | Subscribe | Subscribe Earnings | Google+ Analyst Ratings Network does not provide financial advice and does not issue recommendations or offers to buy or sell any security. Learn more.